NEW YORK (GenomeWeb) – PositiveID today announced that they have signed an agreement to partner with Rockville, Maryland-based GenArraytion.
Under the terms of the agreement, PositiveID will evaluate GenArraytion's assays on its Firefly Dx PCR prototype pathogen detection system.
GenArraytion's MultiFlex Bioassays for pathogens can feature up to 20 DNA or RNA targets per panel, and are designed for use with real-time or bead-based platforms. The configurable, mix-and-match assays have been developed for clinical pathogens, veterinary pathogens, food- and water-borne pathogens, and biological threats.
Financial and other details of the agreement were not disclosed.
In May 2014, Del Ray Beach, Florida-based PositiveID signed a deal to develop military applications for the Firefly Dx system.